Open Access<p>Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma</p>
Author(s) -
Xiaohang Yang,
Zhenyu Hou,
Keyun Zhu,
Su Zhang,
Xiaoying Gu,
Zhiwei Wang,
Han Mu,
Hongyuan Zhou,
Ping Chen,
Xiaolin Zhu,
Yunlong Cui,
Qiang Li,
Huikai Li,
Ti Zhang
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s240394
Subject(s) - apatinib , hepatocellular carcinoma , medicine , drug , oncology , pharmacology , cancer research , cancer
We retrospectively evaluated the efficacy and safety of apatinib as a first-line treatment for advanced hepatocellular carcinoma (HCC) and explored whether drug-related hypertension (HTN) could predict its efficacy.